Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001569383 | SCV001793448 | pathogenic | not provided | 2024-08-13 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 32620954, 23354436, 27102868, 28474983, 33904513, 36268624) |
Revvity Omics, |
RCV001569383 | SCV003827962 | pathogenic | not provided | 2022-06-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001569383 | SCV005838398 | pathogenic | not provided | 2024-08-26 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val498Cysfs*12) in the TCF12 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TCF12 are known to be pathogenic (PMID: 23354436, 32620954). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Kallman syndrome and TCF12-related craniosynostosis (PMID: 32620954, 33904513). ClinVar contains an entry for this variant (Variation ID: 55912). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000049325 | SCV000081757 | pathogenic | TCF12-related craniosynostosis | 2013-03-01 | no assertion criteria provided | literature only | |
OMIM | RCV001818229 | SCV002064294 | pathogenic | HYPOGONADOTROPIC HYPOGONADISM 26 WITH ANOSMIA | 2013-03-01 | no assertion criteria provided | literature only |